Evaluation of the Impact of Participation in a Psycho-education Program for Victims of Sexual Violence (PE-VVS)

March 13, 2026 updated by: Centre Hospitalier Charles Perrens, Bordeaux
Evaluation of the impact of a psycho-education program for victims of sexual violence, to determine the most efficient model to patients.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

In 2022, CRP Sud NA set up a psycho-education group for victims of sexual violence (PE-VVS). Two groups were held, involving 10 patients:

  • Average age = 35 (29-50)
  • Average PCL5 before PE-VSS = 53 (31 - 63)

  • Type of SV experienced

    • In childhood or adolescence outside family environment
    • Incest
    • Rape in adulthood outside intimate relationship
    • Rape by intimate partner A special feature of this therapeutic group is the involvment of the CRP's patient-partner. He took part in both design and facilitation of the sessions, along with the two CRP co-therapists (IDE / psychologist).

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • France
      • Bordeaux, France, 33076
        • Recruiting
        • Centre Hospitalier Charles Perrens
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • At the suggestion of CRP therapists,
  • Patient treated at the CRP having been exposed to sexual violence

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Without group intervention
Patient refusing group care and/or assessment ended after the inclusion end dates
Experimental: With group intervention
Patient in agreement with group management and available for participation
Other: PsychoEducation Program
6 sessions of PsychoEducational Program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of impact on quality of life (QoL) concerning participation in this psychoeducation program
Time Frame: 6 months after the end of program
QoL measurement by Stages of Recovery Instrument "STORI"
6 months after the end of program
Evaluation of impact on self-esteem of participation in this psychoeducation program
Time Frame: 6 months after the end of program
Self-esteem measurement by Rosenberg self-esteem scale
6 months after the end of program
Evaluation of Impact on mental well-being of participation in this psychoeducation program
Time Frame: 6 months after the end of program
Well-being evalutation by Warwick-Edinburgh scale (WEMWBS)
6 months after the end of program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier Charles Perrens, Bordeaux

Investigators

  • Principal Investigator: Chantal BERGEY, Charles Perrens

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2023

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

November 29, 2024

First Submitted That Met QC Criteria

December 4, 2024

First Posted (Actual)

December 5, 2024

Study Record Updates

Last Update Posted (Actual)

March 16, 2026

Last Update Submitted That Met QC Criteria

March 13, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CR-BDX-AP 2023-08

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sexual Violence

Clinical Trials on PsychoEducation Program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe